Literature DB >> 32705331

Recurrent stress urinary incontinence surgery in the United Kingdom: an analysis of the British Society of Urogynaecology database (2007-2015).

Dina El-Hamamsy1, Douglas G Tincello2.   

Abstract

INTRODUCTION AND HYPOTHESIS: There is a lack of robust evidence guiding treatment options for recurrent stress urinary incontinence (SUI) and limited comparative outcome data. The aim of this study was to examine the pattern of surgery for recurrent SUI performed by gynaecologists in the UK and compare subjective success rates.
METHODS: Retrospective review of the British Society of Urogynaecologists database for patients having repeat incontinence procedures (2007-2015) including the number of each procedure and outcome recorded by the International Consultation on Incontinence Urinary Incontinence Short Form (ICIQ-UI-SF) questionnaire. Procedures were compared by year and outcomes by operation. Categorical comparisons were performed using Chi-squared test and numerical comparisons using appropriate non-parametric tests.
RESULTS: A total of 2,938 records were obtained (269 were excluded) and 2,164 women (88.8%) had undergone one previous procedure, most commonly retropubic midurethral sling (MUS; 28.6%). Pelvic floor exercises were offered to 76.2% women. Urodynamic investigation was carried out in 96.2% women: 76.5% had urodynamic stress incontinence. Repeat MUS was the most common procedure (77.3%), followed by bladder neck injections (BNI; 10.2%). Follow-up details were available for 66.1%. Outcome data were poorly reported. Median ICIQ-UI-SF score fell from 16 (0-21) to 0 (0-21) (p < 0.001), 81.6% felt "much better" or "very much better" on Patient Global Impression of Improvement (PGI-I), and 89.3% "cured" or "improved". MUS, colposuspension and fascial sling showed the best results with regard to the PGI-I score and "change in SUI" (p < 0.001).
CONCLUSION: MUS and BNI were the most common repeat continence procedures. Follow-up data suggest that MUS, colposuspension and fascial sling are most effective.

Entities:  

Keywords:  Recurrent incontinence; Repeat surgery; Stress incontinence; Urinary incontinence

Year:  2020        PMID: 32705331      PMCID: PMC7788023          DOI: 10.1007/s00192-020-04420-3

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  4 in total

1.  The efficacy of the tension-free vaginal tape in the treatment of five subtypes of stress urinary incontinence.

Authors:  Jeffrey L Segal; Brett J Vassallo; Steven D Kleeman; Melanie Hungler; Mickey M Karram
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-18

2.  Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.

Authors:  Evangelia Bakali; Eugenie Johnson; Brian S Buckley; Paul Hilton; Ben Walker; Douglas G Tincello
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

3.  Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study.

Authors:  Mohamed Abdel-Fattah; Akinbowale Familusi; Shona Fielding; John Ford; Sohinee Bhattacharya
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

4.  Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques.

Authors:  Ausra Cerniauskiene; Marija Barisiene; Feliksas Jankevicius; Gediminas Januska
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-05-26       Impact factor: 1.195

  4 in total
  2 in total

1.  Risk factors of postpartum stress urinary incontinence in primiparas: What should we care.

Authors:  Jiejun Gao; Xinru Liu; Yan Zuo; Xiaocui Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 2.  A narrative review of pelvic floor muscle training in the management of incontinence following prostate treatment.

Authors:  Marwan Ali; Dylan D Hutchison; Nicolas M Ortiz; Ryan P Smith; David E Rapp
Journal:  Transl Androl Urol       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.